authors
- Biziotis, Olga-Demetra
- Tsakiridis, Evangelia-Evelyn
- Broadfield, Lindsay
- Farrell, Thomas
- Menjolian, Gabe
- Mathurin, Tammy
- Mekhaeil, Bassem
- Zacharidis, Panagiotis
- Muti, Paola
- Abdulkarim, Bassam
- Steinberg, Gregory
- Tsakiridis, Theos
40 Canagliflozin, a New Anti-Diabetic Agent Targeting Cellular Metabolism, Suppresses Survival and Enhances the Response of Non-Small Cell Lung Cancer (NSCLC) to Radiotherapy
Journal Articles
- Overview
- Research
- Identity
- Additional Document Info
- View All
Overview
status
publication date
- October 2019
has subject area
- 0299 Other Physical Sciences (FoR)
- 1112 Oncology and Carcinogenesis (FoR)
- Oncology & Carcinogenesis (Science Metrix)
published in
- Radiotherapy and Oncology Journal